---
title: "Genetic Ancestry Versus Self-Reported Race Alters Neuropsychiatric Symptom Estimates in Alzheimer'"
id: "medrxiv-21-discordance-between-genetic-ancestry-and-self-reported-race-impacts-inference"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-21-discordance-between-genetic-ancestry-and-self-reported-race-impacts-inference"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1?rss=1"
published_at: "2026-08-26T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Genetic Ancestry Versus Self-Reported Race Alters Neuropsychiatric Symptom Estimates in Alzheimer'
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-21-discordance-between-genetic-ancestry-and-self-reported-race-impacts-inference
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1?rss=1)
- **Published At:** 2026-08-26T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study analyzed whole-genome sequencing data from **7,118** participants in the Alzheimer's Disease Sequencing Project (ADSP) to compare genetically inferred ancestry with self-reported race/ethnicity and to assess differences in **neuropsychiatric symptoms (NPS)** prevalence in Alzheimer’s disease (AD). - Neuropsychiatric symptoms studied included aggression, psychosis, anxiety, apathy, and depression, summarized into three NPI-Q clusters: **early psychosis** (CDR 0.5–1), **late psychosis** (CDR 2–3), and **affective symptoms**. - Genetic ancestry was inferred using principal component clustering and yielded six groups: EUR (European), AFR (African), EAS (East Asian), SAS (South Asian), AMR (Admixed American), and ADMIXED. - Assignment based on genetic ancestry diverged substantially from participants’ self-reported race/ethnicity, which materially changed estimates of NPS prevalence across groups. - Affective symptom prevalence was highest in EAS (90%) and SAS (77%) and lowest in AFR (66%). Psychosis prevalence was highest in EAS (74%) and SAS (70%) and lowest in AMR (55%) and EUR (56%), with similar patterns for early and late psychosis clusters. - The authors conclude that relying on standard self-reported race categories may obscure population-level differences in NPS burden, potentially compromising risk stratification, screening, and trial design. - The findings suggest ancestry-associated differences may reflect distinct genetic and environmental contributors and support incorporating **genetic ancestry** into AD research and clinical considerations. - This work is a preprint and has not undergone peer review; the authors note that only de-identified, previously consented data were used and that original studies had IRB approvals. - Data are available via controlled access at the NIAGADS ADSP data repository; the study was supported by multiple NIH grants (National Institute on Aging and National Institute of Mental Health).
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=lTb3z8C.fPUMlUG9gbdLlRU55NozGkvoS_L1oYdkK34-1787764563.9104996-1.2.1.1-eAj2NoLznrxSZx6iSgElVXRXzuLkSQjwlDIdkU7GdX06cFvOS.1bG83_uqpC15Dj) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Discordance Between Genetic Ancestry and Self-Reported Race Impacts Inference of Neuropsychiatric Burden in Alzheimer's Disease [ View ORCID Profile](http://orcid.org/0000-0001-5513-4135)Ajneesh Kumar, Balaji Kannappan, Nicholas R. Ray, Jiji T. Kurup, Pamela Del Rosario, Alyssa N. De Vito, Michael L. Cuccaro, Gary W. Beecham, Edward D. Huey, Christiane Reitz doi: https://doi.org/10.64898/2026.08.23.26361161 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Ajneesh Kumar 1 1Gertrude H. Sergievsky Center, Columbia University, New York, NY 10032, USA , 2Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY 10032, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ajneesh%2BKumar%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kumar%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAjneesh%2BKumar%2B) * [ORCID record for Ajneesh Kumar](http://orcid.org/0000-0001-5513-4135 "Open in new tab") Balaji Kannappan 2 1Gertrude H. Sergievsky Center, Columbia University, New York, NY 10032, USA, 2Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY 10032, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Balaji%2BKannappan%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kannappan%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABalaji%2BKannappan%2B) Nicholas R. Ray 3 1Gertrude H. Sergievsky Center, Columbia University, New York, NY 10032, USA 2Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY 10032, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nicholas%2BR.%2BRay%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ray%20NR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANicholas%2BR.%2BRay%2B) Jiji T. Kurup 3 1Gertrude H. Sergievsky Center, Columbia University, New York, NY 10032, USA 2Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY 10032, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jiji%2BT.%2BKurup%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kurup%20JT&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJiji%2BT.%2BKurup%2B) Pamela Del Rosario 3 1Gertrude H. Sergievsky Center, Columbia University, New York, NY 10032, USA 2Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY 10032, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Pamela%2BDel%2BRosario%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Rosario%20PD&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APamela%2BDel%2BRosario%2B) Alyssa N. De Vito 4 7Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI 02912, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Alyssa%2BN.%2BDe%2BVito%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=De%20Vito%20AN&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAlyssa%2BN.%2BDe%2BVito%2B) Michael L. Cuccaro 5 5The John P. Hussman Institute for Human Genomics, University of Miami, Miami, FL 33136, USA 6Dr. John T. MacDonald Foundation Department of Human Genetics, University of Miami, Miami, FL 33136, USA.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michael%2BL.%2BCuccaro%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Cuccaro%20ML&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMichael%2BL.%2BCuccaro%2B) Gary W. Beecham 6 8Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Gary%2BW.%2BBeecham%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Beecham%20GW&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGary%2BW.%2BBeecham%2B) Edward D. Huey 4 7Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI 02912, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Edward%2BD.%2BHuey%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Huey%20ED&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEdward%2BD.%2BHuey%2B) Christiane Reitz 7 1Gertrude H. Sergievsky Center, Columbia University, New York, NY 10032, USA 2Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY 10032, USA 3Department of Neurology, Columbia University, New York, NY * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Christiane%2BReitz%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Reitz%20C&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AChristiane%2BReitz%2B) * For correspondence: cr2101@cumc.columbia.edu * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1286657/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1286657/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1286657/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1286657/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1286657/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1286657/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Introduction. Neuropsychiatric symptoms (NPS), including aggression, psychosis, anxiety, apathy, and depression, affect up to 85% of individuals with Alzheimer's disease (AD) and are among its most disabling and costly manifestations, accelerating cognitive and functional decline, institutionalization, mortality, and healthcare costs. NPS prevalence has largely been characterized using self-reported race. Whether NPS differs across genetically defined ancestry groups and whether self-reported race obscures these differences remains unknown, limiting accurate risk stratification and treatment development. Methods. Using whole-genome sequencing data from 7,118 ADSP participants, we defined three NPS clusters from the NPI-Q: early psychosis (CDR 0.5-1), late psychosis (CDR 2-3), and affective symptoms. Genetic ancestry was inferred by principal component clustering, identifying six groups (EUR, AFR, EAS, SAS, AMR, ADMIXED), and compared with self-reported race/ethnicity. NPS prevalence was compared across genetic ancestry groups and genetic ancestry and self-reported race using Fisher's exact and regression models. Results. Genetic ancestry assignment differed markedly from self-reported race, affecting NPS prevalence estimates. NPS prevalence also differed across ancestry groups; affective symptoms were highest in EAS (90%) and SAS (77%) and lowest in AFR (66%), while psychosis was highest in EAS (74%) and SAS (70%) and lowest in AMR (55%) and EUR (56%), with similar patterns for early and late psychosis. Discussion. Genetically defined ancestry alters NPS prevalence estimates in AD, suggesting that standard race categories obscure population-level disease burden and compromise risk stratification, screening, and trial design. Ancestry-associated differences suggest partially distinct genetic and environmental drivers, underscoring the need to incorporate genetic ancestry into AD research and care. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study utilized only de-identified, clinical, demographic and whole-genome sequencing data. No new human subjects were recruited or directly studied. All original studies from which these data were derived obtained informed consent from participants and received approval from their respective institutional review boards (IRBs). Therefore, additional informed consent was not required for this secondary analysis. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The data used in this study are available through the National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (NIAGADS) Data Sharing Service. Access to individual-level Alzheimer's Disease Sequencing Project (ADSP) data is controlled and requires an approved data access request in accordance with NIAGADS and NIH data-use policies. ## Funder Information Declared National Institute on Aging, P30AG066462 (CR), U01AG079850 (CR, GB, EH), R01AG064614 (CR, GB), U24AG074855 (GB, MC), R01AG062268 (EH) National Institute of Mental Health, https://ror.org/04xeg9z08, R01MH120794(EH) Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-ND 4.0 International license](http://creativecommons.org/licenses/by-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.21.26361025v1 "Acquisition of Group B streptococcus colonization in preterm pregnancy")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.21.26358780v1 "Cross-trait and multi-polytranscriptomic score analysis of Parkinson's disease identifies novel associations and improves prediction") Posted August 26, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/26/2026.08.23.26361161.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.08.23.26361161v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/26/2026.08.23.26361161.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Discordance Between Genetic Ancestry and Self-Reported Race Impacts Inference of Neuropsychiatric Burden in Alzheimer's Disease Ajneesh Kumar, Balaji Kannappan, Nicholas R. Ray, Jiji T. Kurup, Pamela Del Rosario, Alyssa N. De Vito, Michael L. Cuccaro, Gary W. Beecham, Edward D. Huey, Christiane Reitz medRxiv 2026.08.23.26361161; doi: https://doi.org/10.64898/2026.08.23.26361161 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.23.26361161v1%26text%3DDiscordance%2520Between%2520Genetic%2520Ancestry%2520and%2520Self-Reported%2520Race%2520Impacts%2520Inference%2520of%2520Neuropsychiatric%2520Burden%2520in%2520Alzheimer%2527s%2520Disease "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.23.26361161v1%26t%3DDiscordance%2520Between%2520Genetic%2520Ancestry%2520and%2520Self-Reported%2520Race%2520Impacts%2520Inference%2520of%2520Neuropsychiatric%2520Burden%2520in%2520Alzheimer%2527s%2520Disease "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.23.26361161v1%26title%3DDiscordance%2520Between%2520Genetic%2520Ancestry%2520and%2520Self-Reported%2520Race%2520Impacts%2520Inference%2520of%2520Neuropsychiatric%2520Burden%2520in%2520Alzheimer%2527s%2520Disease%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.23.26361161v1%26title%3DDiscordance%2520Between%2520Genetic%2520Ancestry%2520and%2520Self-Reported%2520Race%2520Impacts%2520Inference%2520of%2520Neuropsychiatric%2520Burden%2520in%2520Alzheimer%2527s%2520Disease "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.23.26361161) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.23.26361161v1&count=horizontal&via=&text=Discordance%20Between%20Genetic%20Ancestry%20and%20Self-Reported%20Race%20Impacts%20Inference%20of%20Neuropsychiatric%20Burden%20in%20Alzheimer%27s%20Disease&counturl=www.medrxiv.org/content/10.64898/2026.08.23.26361161v1 "Tweet This") ## Subject Area * [Neurology ](https://www.medrxiv.org/collection/neurology) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (611) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (892) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (325) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4751) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (473) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (406) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (639) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1609) * [Epidemiology](https://www.medrxiv.org/collect
## Related Clinical Research

- [2026 Stroke Rehabilitation Guideline: Start Early and Address Physical, Cognitive, and Mental Heal](https://medichelpline.com/clinical-feed/medical-news-today-0-stroke-rehab-guidelines-emphasize-early-support-for-physical-cognitive-and.md)
- [Diet and Alzheimer’s risk: Why no single best diet fits everyone](https://medichelpline.com/clinical-feed/medical-news-today-0-is-there-a-best-diet-to-help-lower-alzheimer-s-risk.md)
- [Pre-diagnostic 1-year prevalence of polypharmacy and PIMcog in Norwegian outpatients with MCI or d](https://medichelpline.com/clinical-feed/plos-one-14-one-year-pre-diagnostic-prevalence-and-associated-factors-of-polypharmacy-and.md)
- [Microglial TLR4 Drives Post‑UTI Chronic Pelvic Pain via Persistent Microglial Activation](https://medichelpline.com/clinical-feed/biorxiv-5-microglial-tlr4-mediates-post-uti-chronic-pelvic-pain.md)
- [EEG-derived indices classify sporadic Creutzfeldt-Jakob disease from Alzheimer’s and healthy aging](https://medichelpline.com/clinical-feed/plos-one-17-classification-of-sporadic-creutzfeldt-jakob-disease-based-on-resting-state.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.